ARIAD PHARMACEUTICALS INCORPORATED
- 26 LANDSDOWNE STREET
02139 CAMBRIDGE, MA
GEO: 42.360865, -71.099285
Phone: (617) 494-0400
Fax: (801) 571-5015
E-mail: Send messagewww.ariad.com
Short profile:
ARIAD is developing breakthrough medicines that regulate cell signaling pathways implicated in cancer Our pipeline includes a series of small molecule product candidates that provide targeted and highly potent anti cancer activity to treat solid tumors and hematologic cancers, as well as the spread of tumors to distant sites Our lead candidate ridaforolimus, a novel mTOR inhibitor has been given fast track designation by the FDA for the treatment of soft tissue and bone sarcomas
Keywords:
conditional knock out, Drug Screening, Regulated signal transduction, Immune diseases, erythropoietin, Cell therapy, rapid, service, gene, Epo, Cell biology, Molecular genomics, Target validation, GvHD, ZAP 70, Kinase Inhibitor, Bone resorption, Regulated gene therapy, personal care services, Gene regulation, Inflammation, T cells, Protein kinase, Stem cell therapy, Anemia, Gene based medicine, Tyrosine kinase, RPD, Oncogenes, Src, small molecule, Drug discovery, Regulation Kit, Signal transduction, health beauty aids, aid retail, gene switch, Bone marrow transplantation, Stem cells, Genomics, NF kappaB, Heterodimerization, ARGENT, Homodimerization, ridaforolimus, NF AT, Protein engineering, inducible knock out mouse, Src gene, Regulated cell therapy, Product validation, Gene activation, Osteoclasts, Osteoblasts, rage, RGE, BMT, Gene therapy, NF kB, Regulated gene transcription, Inducible gene expression, AP1903, Proteomics, Cancer drug, Structure based drug design
